The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease in the developed world. Until 2016, the only treatment that was clearly demonstrated to delay the DKD was the renin-angiotensin system blockade, either by angiotensin-converting enzyme inhibitors or angiotensin receptor bl...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Carro, Clara, Vergara, Ander, Agraz, Irene, Jacobs-Cachá, Conxita, Espinel, Eugenia, Seron, Daniel, Soler, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617211/
https://www.ncbi.nlm.nih.gov/pubmed/31212945
http://dx.doi.org/10.3390/jcm8060864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617211/
https://www.ncbi.nlm.nih.gov/pubmed/31212945
http://dx.doi.org/10.3390/jcm8060864

Ejemplares similares